Trial Outcomes & Findings for Functional Electrical Stimulation Use in Trans-tibial Amputations (NCT NCT02931396)

NCT ID: NCT02931396

Last Updated: 2024-12-02

Results Overview

Residual limb knee extension isometric strength was tested using a standardized Biodex protocol and custom attachment. The lever arm of the Biodex was positioned at 60 degrees of knee flexion, with the support cushion modified for the amputee and positioned at the mid-tibia. The participant was asked to extend their knee against the arm as hard as they could for five seconds.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

20 participants

Primary outcome timeframe

baseline and 12 weeks

Results posted on

2024-12-02

Participant Flow

Participant milestones

Participant milestones
Measure
FES Intervention
Study participants who are randomized into the intervention group will be fitted with a portable commercially available surface FES device and instructed in its use by a study investigator. Participants will be directed to use the FES 30 minutes a day for the first week, one hour a day during the next week, 90 minutes a day during the third week, and then a minimum of 2 hours per day or 10 hours per week for the next three months at home. FES
Control
Participants will be asked to continue their activities of daily living as usual.
Overall Study
STARTED
10
10
Overall Study
COMPLETED
5
10
Overall Study
NOT COMPLETED
5
0

Reasons for withdrawal

Reasons for withdrawal
Measure
FES Intervention
Study participants who are randomized into the intervention group will be fitted with a portable commercially available surface FES device and instructed in its use by a study investigator. Participants will be directed to use the FES 30 minutes a day for the first week, one hour a day during the next week, 90 minutes a day during the third week, and then a minimum of 2 hours per day or 10 hours per week for the next three months at home. FES
Control
Participants will be asked to continue their activities of daily living as usual.
Overall Study
Lost to Follow-up
3
0
Overall Study
Withdrawal by Subject
2
0

Baseline Characteristics

Functional Electrical Stimulation Use in Trans-tibial Amputations

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
FES Intervention
n=10 Participants
Study participants who are randomized into the intervention group will be fitted with a portable commercially available surface FES device and instructed in its use by a study investigator. Participants will be directed to use the FES 30 minutes a day for the first week, one hour a day during the next week, 90 minutes a day during the third week, and then a minimum of 2 hours per day or 10 hours per week for the next three months at home. FES
Control
n=10 Participants
Participants will be asked to continue their activities of daily living as usual.
Total
n=20 Participants
Total of all reporting groups
Age, Continuous
55.7 years
STANDARD_DEVIATION 10.4 • n=5 Participants
49.9 years
STANDARD_DEVIATION 16.8 • n=7 Participants
52.8 years
STANDARD_DEVIATION 13.9 • n=5 Participants
Sex: Female, Male
Female
3 Participants
n=5 Participants
2 Participants
n=7 Participants
5 Participants
n=5 Participants
Sex: Female, Male
Male
7 Participants
n=5 Participants
8 Participants
n=7 Participants
15 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
10 Participants
n=5 Participants
10 Participants
n=7 Participants
20 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Asian
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Black or African American
1 Participants
n=5 Participants
2 Participants
n=7 Participants
3 Participants
n=5 Participants
Race (NIH/OMB)
White
9 Participants
n=5 Participants
8 Participants
n=7 Participants
17 Participants
n=5 Participants
Race (NIH/OMB)
More than one race
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants

PRIMARY outcome

Timeframe: baseline and 12 weeks

Residual limb knee extension isometric strength was tested using a standardized Biodex protocol and custom attachment. The lever arm of the Biodex was positioned at 60 degrees of knee flexion, with the support cushion modified for the amputee and positioned at the mid-tibia. The participant was asked to extend their knee against the arm as hard as they could for five seconds.

Outcome measures

Outcome measures
Measure
FES Intervention
n=5 Participants
Study participants who are randomized into the intervention group will be fitted with a portable commercially available surface FES device and instructed in its use by a study investigator. Participants will be directed to use the FES 30 minutes a day for the first week, one hour a day during the next week, 90 minutes a day during the third week, and then a minimum of 2 hours per day or 10 hours per week for the next three months at home. FES
Control
n=10 Participants
Participants will be asked to continue their activities of daily living as usual.
Change in Knee Extension Isometric Strength (Peak Torque) Using the Biodex Measurement System
-0.1 Nm/kg
Interval -6.0 to 5.7
2.2 Nm/kg
Interval -1.4 to 5.8

PRIMARY outcome

Timeframe: baseline and 12 weeks

3-D motion-tracking laser scanning system was used to determine residual limb volume in cm

Outcome measures

Outcome measures
Measure
FES Intervention
n=5 Participants
Study participants who are randomized into the intervention group will be fitted with a portable commercially available surface FES device and instructed in its use by a study investigator. Participants will be directed to use the FES 30 minutes a day for the first week, one hour a day during the next week, 90 minutes a day during the third week, and then a minimum of 2 hours per day or 10 hours per week for the next three months at home. FES
Control
n=10 Participants
Participants will be asked to continue their activities of daily living as usual.
Change in Residual Limb Volume Using 3-D Scanner
-1.6 cm
Interval -13.9 to 10.7
23.9 cm
Interval -39.8 to 87.6

PRIMARY outcome

Timeframe: baseline and 12 weeks

Scores were reported on a 0 to 10 scale with higher scores representing higher pain levels

Outcome measures

Outcome measures
Measure
FES Intervention
n=5 Participants
Study participants who are randomized into the intervention group will be fitted with a portable commercially available surface FES device and instructed in its use by a study investigator. Participants will be directed to use the FES 30 minutes a day for the first week, one hour a day during the next week, 90 minutes a day during the third week, and then a minimum of 2 hours per day or 10 hours per week for the next three months at home. FES
Control
n=10 Participants
Participants will be asked to continue their activities of daily living as usual.
Change in Residual Limb Pain Using Likert Scale Pain Questionnaire
-1.2 units on a scale
Interval -2.8 to 0.4
1.5 units on a scale
Interval -0.6 to 3.6

Adverse Events

FES Intervention

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Control

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Alicia Koontz

University of Pittsburgh

Phone: 4128223700

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place